BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1474538)

  • 1. NSAID, ulcers, and prostaglandins.
    Kimmey MB
    J Rheumatol Suppl; 1992 Nov; 36():68-73. PubMed ID: 1474538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM; Saggioro A
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
    Dajani EZ; Agrawal NM
    Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
    Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
    Festen HP
    Neth J Med; 1989 Dec; 35(5-6):327-33. PubMed ID: 2699655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of arthritis antiinflammatory care: where are we today?
    Simon LS
    J Rheumatol Suppl; 1999 Apr; 56():11-7. PubMed ID: 10225535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS; Beglinger C
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
    McCarthy DM
    J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori.
    Mizokami Y; Tamura K; Fukuda Y; Yamamoto I; Shimoyama T
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S109-12. PubMed ID: 7735925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN; Smith JL; Lidsky MD; Graham DY
    Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
    McCarthy DM
    Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: mechanisms and prevention.
    Rich M; Scheiman JM
    Semin Arthritis Rheum; 2000 Dec; 30(3):167-79. PubMed ID: 11124281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury?
    Dajani EZ
    Am J Gastroenterol; 1996 May; 91(5):835-6. PubMed ID: 8633566
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
    J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
    Laine L
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
    Wallace JL
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment].
    Martín de Argila C; Moreira V; Gisbert JP
    An Med Interna; 1995 Feb; 12(2):85-96. PubMed ID: 7749017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.